Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Services
Cleanroom Services Partnership Brings Synergy for Customers
Thursday, May 01, 2014
Two award-winning laboratory service providers have joined forces to create greater synergy for customers.
Quotient Clinical Extends its Translational Pharmaceutics™ Platform
Friday, April 25, 2014
Company will employ its manufacturing capabilities to supply specialist oncology centers with drug products.
New Approach to Temperature Control in Cell Therapy Clinical Trial
Wednesday, April 23, 2014
CoolCell® cell freezing device and CoolBox™ ice-free cooling workstations chosen to support handling and processing of investigational cell therapy product in landmark clinical research trial.
Critical Pharmaceuticals, The University of Nottingham and NUH Starts First Phase I Clinical Trial
Wednesday, April 16, 2014
Phase I clinical trial on a nano-enabled intranasal teriparatide for the treatment of osteoporosis.
ERT Introduces GE Healthcare’s QT Guard Plus™ Analysis System
Friday, April 11, 2014
Novel approach may help to prevent false positive cardiac safety findings in new drug development.
Vetter Launches New Clinical Syringe Packages
Friday, April 11, 2014
Earlier syringe development may cut time-to-market, increase clinical trial appeal.
Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
Wednesday, April 09, 2014
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.
Epistem Announces Installation of UKs First Bruker Xtreme Imaging System
Tuesday, April 08, 2014
Xtreme system will enable Epistem to expand both the range and throughput of its imaging services.
Vetter to Implement Serialization to Support Track-and-Trace Efforts
Friday, March 28, 2014
Flexible service offering planned to go into effect in 2014.
Showing Results 31 - 40 of 312
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,800+ scientific and medical posters
4,000+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!